These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 31925905)

  • 21. Alterations in gut microbial function following liver transplant.
    Bajaj JS; Kakiyama G; Cox IJ; Nittono H; Takei H; White M; Fagan A; Gavis EA; Heuman DM; Gilles HC; Hylemon P; Taylor-Robinson SD; Legido-Quigley C; Kim M; Xu J; Williams R; Sikaroodi M; Pandak WM; Gillevet PM
    Liver Transpl; 2018 Jun; 24(6):752-761. PubMed ID: 29500907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gut Microbial Dysbiosis Is Associated with Altered Hepatic Functions and Serum Metabolites in Chronic Hepatitis B Patients.
    Wang J; Wang Y; Zhang X; Liu J; Zhang Q; Zhao Y; Peng J; Feng Q; Dai J; Sun S; Zhao Y; Zhao L; Zhang Y; Hu Y; Zhang M
    Front Microbiol; 2017; 8():2222. PubMed ID: 29180991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pathophysiology of bile acid diarrhoea: differences in the colonic microbiome, metabolome and bile acids.
    Sagar NM; Duboc H; Kay GL; Alam MT; Wicaksono AN; Covington JA; Quince C; Kokkorou M; Svolos V; Palmieri LJ; Gerasimidis K; Walters JRF; Arasaradnam RP
    Sci Rep; 2020 Nov; 10(1):20436. PubMed ID: 33235223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bile acids, gut microbiota, and therapeutic insights in hepatocellular carcinoma.
    Song Y; Lau HC; Zhang X; Yu J
    Cancer Biol Med; 2023 Dec; 21(2):144-62. PubMed ID: 38148326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut microbiota, cirrhosis, and alcohol regulate bile acid metabolism in the gut.
    Ridlon JM; Kang DJ; Hylemon PB; Bajaj JS
    Dig Dis; 2015; 33(3):338-45. PubMed ID: 26045267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Commensal Microbe Veillonella as a Marker for Response to an FGF19 Analog in NASH.
    Loomba R; Ling L; Dinh DM; DePaoli AM; Lieu HD; Harrison SA; Sanyal AJ
    Hepatology; 2021 Jan; 73(1):126-143. PubMed ID: 32794259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease.
    Li L; Liu T; Gu Y; Wang X; Xie R; Sun Y; Wang B; Cao H
    Front Immunol; 2022; 13():974305. PubMed ID: 36211363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Western Diet Aggravated Carbon Tetrachloride-Induced Chronic Liver Injury by Disturbing Gut Microbiota and Bile Acid Metabolism.
    Yang L; Li Y; Wang S; Bian X; Jiang X; Wu J; Wang K; Wang Q; Xia J; Jiang S; Zhuge A; Yuan Y; Li S; Li L
    Mol Nutr Food Res; 2021 Apr; 65(7):e2000811. PubMed ID: 33458949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Network Involving Gut Microbiota, Circulating Bile Acids, and Hepatic Metabolism Genes That Protects Against Non-Alcoholic Fatty Liver Disease.
    Petrov PD; García-Mediavilla MV; Guzmán C; Porras D; Nistal E; Martínez-Flórez S; Castell JV; González-Gallego J; Sánchez-Campos S; Jover R
    Mol Nutr Food Res; 2019 Oct; 63(20):e1900487. PubMed ID: 31322321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of metabolome changes in the bile acid pool in feces and plasma of antibiotic-treated rats.
    Behr C; Slopianka M; Haake V; Strauss V; Sperber S; Kamp H; Walk T; Beekmann K; Rietjens IMCM; van Ravenzwaay B
    Toxicol Appl Pharmacol; 2019 Jan; 363():79-87. PubMed ID: 30502395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gut Microbiota Dysbiosis Is Associated with Altered Bile Acid Metabolism in Infantile Cholestasis.
    Wang Y; Gao X; Zhang X; Xiao Y; Huang J; Yu D; Li X; Hu H; Ge T; Li D; Zhang T
    mSystems; 2019 Dec; 4(6):. PubMed ID: 31848302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disease-Associated Gut Microbiota Reduces the Profile of Secondary Bile Acids in Pediatric Nonalcoholic Fatty Liver Disease.
    Yu J; Zhang H; Chen L; Ruan Y; Chen Y; Liu Q
    Front Cell Infect Microbiol; 2021; 11():698852. PubMed ID: 34568090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota.
    Chen ML; Yi L; Zhang Y; Zhou X; Ran L; Yang J; Zhu JD; Zhang QY; Mi MT
    mBio; 2016 Apr; 7(2):e02210-15. PubMed ID: 27048804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome.
    MahmoudianDehkordi S; Arnold M; Nho K; Ahmad S; Jia W; Xie G; Louie G; Kueider-Paisley A; Moseley MA; Thompson JW; St John Williams L; Tenenbaum JD; Blach C; Baillie R; Han X; Bhattacharyya S; Toledo JB; Schafferer S; Klein S; Koal T; Risacher SL; Kling MA; Motsinger-Reif A; Rotroff DM; Jack J; Hankemeier T; Bennett DA; De Jager PL; Trojanowski JQ; Shaw LM; Weiner MW; Doraiswamy PM; van Duijn CM; Saykin AJ; Kastenmüller G; Kaddurah-Daouk R;
    Alzheimers Dement; 2019 Jan; 15(1):76-92. PubMed ID: 30337151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased Secondary/Primary Bile Acid Ratio in Chronic Heart Failure.
    Mayerhofer CCK; Ueland T; Broch K; Vincent RP; Cross GF; Dahl CP; Aukrust P; Gullestad L; Hov JR; Trøseid M
    J Card Fail; 2017 Sep; 23(9):666-671. PubMed ID: 28688889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel approaches in IBD therapy: targeting the gut microbiota-bile acid axis.
    Pan Y; Zhang H; Li M; He T; Guo S; Zhu L; Tan J; Wang B
    Gut Microbes; 2024; 16(1):2356284. PubMed ID: 38769683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Taurine-conjugated bile acids and their link to hepatic S1PR2 play a significant role in hepatitis C-related liver disease.
    Ali RO; Haddad JA; Quinn GM; Zhang GY; Townsend E; Scheuing L; Hill KL; Menkart M; Oringher JL; Umarova R; Rampertaap S; Rosenzweig SD; Koh C; Levy EB; Kleiner DE; Etzion O; Heller T
    Hepatol Commun; 2024 Jul; 8(7):. PubMed ID: 38967598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum angiotensin-converting enzyme level as a marker of fibrosis in patients with chronic hepatitis B.
    Purnak T; Beyazit Y; Oztas E; Yesil Y; Efe C; Torun S; Celik T; Tenlik I; Kurt M; Ozaslan E
    J Renin Angiotensin Aldosterone Syst; 2012 Jun; 13(2):244-9. PubMed ID: 22277254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut microbiota-associated bile acid deconjugation accelerates hepatic steatosis in ob/ob mice.
    Park MY; Kim SJ; Ko EK; Ahn SH; Seo H; Sung MK
    J Appl Microbiol; 2016 Sep; 121(3):800-10. PubMed ID: 27111464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of compensated advanced chronic liver disease based on serum bile acids in chronic hepatitis B patients.
    Chen F; Yao Y; Li Z; Deng L; He R
    Sci Rep; 2023 Aug; 13(1):12834. PubMed ID: 37553441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.